Aspirin 75mg tablets

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ակտիվ բաղադրիչ:

Aspirin

Հասանելի է:

Kent Pharma (UK) Ltd

ATC կոդը:

B01AC06

INN (Միջազգային անվանումը):

Aspirin

Դոզան:

75mg

Դեղագործական ձեւ:

Oral tablet

Կառավարման երթուղին:

Oral

Դաս:

No Controlled Drug Status

Ռեկվիզորի տեսակը:

Valid as a prescribable product

Ապրանքի ամփոփագիր:

BNF: 02090000; GTIN: 5039021002484

Տեղեկատվական թերթիկ

• Keep this leaflet. You may need to
read it again.
• If you have any further questions
please ask your doctor or
pharmacist.
• This medicine has been
prescribed for you personally and
you should not pass it on to others.
It may harm them, even if their
symptoms are the same as yours.
• If any of the side effects gets
serious, or if you notice any side
effects not listed in this leaflet,
please tell your doctor or
pharmacist.
In this leaflet:
1. What Aspirin Tablets 75mg are
and what they are used for
2. Before you take Aspirin Tablets
75mg
3. How to take Aspirin Tablets 75mg
4. Possible side effects
5. How to store Aspirin Tablets
75mg
6. Further information
1. WHAT ASPIRIN TABLETS 75MG
ARE AND WHAT THEY ARE USED FOR
• Each tablet contains the active
ingredient Aspirin 75 mg.
• Aspirin (acetylsalicylic acid)
belongs to a group of medicines
called antiplatelet agents that help
prevent your blood cells sticking
together and forming a blood clot.
• Aspirin Tablets 75mg are
principally used to prevent blood
clots forming following a heart
attack or stroke or to help prevent
heart attacks and strokes in
patients who have previously
suffered from these conditions.
They may have been prescribed
for you if you have recently had
by-pass surgery.
2. BEFORE YOU TAKE ASPIRIN
TABLETS 75MG
DO NOT TAKE THIS MEDICINE IF YOU:
• are ALLERGIC TO ACETYLSALICYLIC
ACID or any of the ingredients in
Aspirin tablets (see section 6
“Further information”)
• are ALLERGIC TO OTHER
SALICYLATES OR NONSTEROIDAL
ANTI-INFLAMMATORY DRUGS
(NSAIDs). NSAIDs are often
used for ARTHRITIS or RHEUMATISM
and pain
• have had an ASTHMA attack or
SWELLING of some parts of the
body e.g. face, lips, throat or
tongue (angioedema) after taking
salicylates or NSAIDs
• currently have or have ever had
an ULCER in your stomach or
small intestine or any other type
of bleeding like a STROKE
• have ever had the problem of
your BLOOD NOT CLOTTING properly
• are suffering from GOUT
• have SEVERE LIVER or KIDNEY
problems
• are in your la

Ապրանքի հատկությունները

1
NAME OF THE MEDICINAL PRODUCT
Aspirin 75mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains the active ingredient:
Aspirin
75.0 mg
3
PHARMACEUTICAL FORM
Orange, flat bevelled edge tablet with breakline on one face.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the secondary prevention of thrombotic cerebrovascular or
cardiovascular
disease and following by-pass surgery.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For the management of cardiovascular or cerebrovascular disease:
The advice of a doctor should be sought before commencing therapy for
the first time.
The usual dosage, for long term use, is 75-150 mg once daily. In some
circumstances
a higher dose may be appropriate, especially in the short term, and up
to 300 mg a day
may be used on the advice of a doctor. In general, acetylsalicylic
acids should be used
with caution in elderly patients who are more prone to adverse events.
The usual adult
dose is recommended in the absence of severe renal or hepatic
insufficiency (see
sections 4.3 and 4.4). Treatment should be reviewed at regular
intervals.
These tablets should be taken orally with a drink of water.
Children: Aspirin 75mg Tablets is not indicated for use in children
and young people
less than 16 years of age (see ‘Special Warnings and Precautions for
Use’).
4.3
CONTRAINDICATIONS
-
Hypersensitivity to salicylic acid compounds or prostaglandin
synthetase inhibitors (e.g.
certain asthma patients who may suffer an attack or faint and certain
patients who may
suffer from bronchospasm, rhinitis and urticaria) and to any of the
excipients;
-
Active, or history of recurrent peptic ulcer and/or gastric/intestinal
haemorrhage, or other
kinds of bleeding such as cerebrovascular haemorrhages;
-
Haemorrhagic diathesis; coagulation disorders such as haemophilia and
thrombocytopenia;
-
Patients who are suffering from gout;
-
Severe hepatic impairment;
-
Severe renal impairment;
-
Doses >100 mg/day during the third trimester of pregnancy (see section
4.6);
-
Methotrexate used at do